Withdrawn application: Dupixent, 18/02/2025

Personalised medicine in oncology

Cancer medicines

Release notes - production release version 1.7.2541 - 7 November 2025 - Veterinary Medicinal Products Regulation: Union Product Database

Clinical Trial Information System (CTIS) - Sponsor handbook

Human medicines European public assessment report (EPAR): Cubicin, daptomycin, Date of authorisation: 19/01/2006, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR): Zepatier, elbasvir,grazoprevir, Date of authorisation: 22/07/2016, Revision: 16, Status: Authorised

HMA/EMA multi-stakeholder workshop on artificial intelligence, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 20 November 2025, 13:30 (CET) to 21 November 2025, 12:45 (CET)

Human medicines European public assessment report (EPAR): Bridion, sugammadex, Date of authorisation: 25/07/2008, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Quadramet, samarium [153Sm] lexidronam pentasodium, Date of authorisation: 04/02/1998, Revision: 17, Status: Authorised